影响核基质蛋白22假阳性结果的因素。 - Suppr | 超能文献

相似文献

1

Factors influencing false-positive results for nuclear matrix protein 22.影响核基质蛋白22假阳性结果的因素。

Eur Urol. 2014 Nov;66(5):970-2. doi: 10.1016/j.eururo.2014.06.014. Epub 2014 Jun 26.

2

Urothelial bladder cancer: biomarkers for detection and screening.尿路上皮膀胱癌：用于检测和筛查的生物标志物

BJU Int. 2008 Nov;102(9 Pt B):1234-41. doi: 10.1111/j.1464-410X.2008.07965.x.

3

Urine concentration of nuclear matrix protein 22 for diagnosis of transitional cell carcinoma of bladder.尿核基质蛋白22浓度用于膀胱移行细胞癌的诊断。

Urol J. 2008 Fall;5(4):243-7.

4

Overestimation of nuclear matrix protein 22 in concentrated urine.尿核基质蛋白 22 浓度过高。

Urology. 2013 Nov;82(5):1059-64. doi: 10.1016/j.urology.2013.05.056. Epub 2013 Sep 14.

5

Urinary tumor marker in bladder carcinoma in Upper Egypt, correlations with different clinicopathological features.埃及上埃及地区膀胱癌中的尿液肿瘤标志物及其与不同临床病理特征的相关性

Saudi J Kidney Dis Transpl. 2012 Sep;23(5):1068-73. doi: 10.4103/1319-2442.100957.

6

Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection.包括即时检测核基质蛋白-22检测和细胞学检查在内的临床因素对膀胱癌检测的影响。

BJU Int. 2009 May;103(10):1368-74. doi: 10.1111/j.1464-410X.2009.08360.x. Epub 2009 Mar 11.

7

Neural network using combined urine nuclear matrix protein-22, monocyte chemoattractant protein-1 and urinary intercellular adhesion molecule-1 to detect bladder cancer.使用联合尿核基质蛋白-22、单核细胞趋化蛋白-1和尿细胞间黏附分子-1检测膀胱癌的神经网络

J Urol. 2003 Mar;169(3):917-20. doi: 10.1097/01.ju.0000051322.60266.06.

8

Comparison of the sensitivity and specificity of urine cytology, urinary nuclear matrix protein-22 and multitarget fluorescence in situ hybridization assay in the detection of bladder cancer.尿液细胞学检查、尿核基质蛋白-22及多靶点荧光原位杂交检测法在膀胱癌检测中的敏感性和特异性比较

Scand J Urol Nephrol. 2011 Mar;45(2):113-21. doi: 10.3109/00365599.2010.533694. Epub 2010 Nov 22.

9

Stress proteins and cytokines are urinary biomarkers for diagnosis and staging of bladder cancer.应激蛋白和细胞因子是膀胱癌诊断和分期的尿生物标志物。

Eur Urol. 2011 Jan;59(1):113-9. doi: 10.1016/j.eururo.2010.10.008. Epub 2010 Oct 15.

10

Comparison of nuclear matrix protein 22 and bladder tumor antigen in urine of patients with bladder cancer.

Anticancer Res. 1998 Sep-Oct;18(5B):3803-5.

引用本文的文献

1

Use of the Nuclear Matrix Protein 22 BladderChek Test for the Detection of Primary and Recurrent Urothelial Carcinoma.核基质蛋白 22 膀胱 Chek 测试在原发性和复发性尿路上皮癌检测中的应用。

Dis Markers. 2020 May 8;2020:3424039. doi: 10.1155/2020/3424039. eCollection 2020.

2

Overexpression of Karyopherin Subunit alpha 2 (KPNA2) Predicts Unfavorable Prognosis and Promotes Bladder Cancer Tumorigenicity via the P53 Pathway.核转运蛋白α2亚基（KPNA2）的过表达预示不良预后并通过P53途径促进膀胱癌致瘤性。

Med Sci Monit. 2020 Mar 9;26:e921087. doi: 10.12659/MSM.921087.

3

and DNA Methylation Biomarker Test (EI-BLA) for Urine-Based Non-Invasive Detection of Bladder Cancer.